Search research articles
Contact Us
Filters
Showing results (901-910 of 1,171) with videos related to
Page
of 118
Sort By:
ESMO Open
|
May 13, 2025
A phase I/II study of the safety and efficacy of telaglenastat (CB-839) in combination with nivolumab in patients with metastatic melanoma, renal cell carcinoma, and non-small-cell lung cancer
M A Gouda, M H Voss, H Tawbi, et al.
NPJ Breast Cancer
|
April 26, 2025
MUC1-C dependency in drug resistant HR+/HER2- breast cancer identifies a new target for antibody-drug conjugate treatment
Ayako Nakashoji, Atrayee Bhattacharya, Hiroki Ozawa, et al.
Oncogene
|
February 22, 2007
The major lung cancer-derived mutants of ERBB2 are oncogenic and are associated with sensitivity to the irreversible EGFR/ERBB2 inhibitor HKI-272
Y Minami, T Shimamura, K Shah, et al.
JAMA Network Open
|
October 18, 2022
Diagnostic Accuracy of a Bacterial and Viral Biomarker Point-of-Care Test in the Outpatient Setting
Nathan I Shapiro, Michael R Filbin, Peter C Hou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 12, 2013
Co-clinical trials demonstrate superiority of crizotinib to chemotherapy in ALK-rearranged non-small cell lung cancer and predict strategies to overcome resistance
Zhao Chen, Esra Akbay, Oliver Mikse, et al.
Acta Physiologica (Oxford, England)
|
March 22, 2021
The Na/K-ATPase α1/Src interaction regulates metabolic reserve and Western diet intolerance
Laura C Kutz, Xiaoyu Cui, Jeffrey X Xie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 29, 2012
A phase I first-in-human trial of bardoxolone methyl in patients with advanced solid tumors and lymphomas
David S Hong, Razelle Kurzrock, Jeffrey G Supko, et al.
Journal of the American Society of Nephrology : JASN
|
April 14, 2006
Non-contrast-enhanced computerized tomography and analgesic-related kidney disease: report of the national analgesic nephropathy study
William L Henrich, Richard L Clark, Judith P Kelly, et al.
Molecular Cancer Research : MCR
|
November 29, 2022
MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast Cancer
Nami Yamashita, Yoshihiro Morimoto, Atsushi Fushimi, et al.
Cancer
|
April 26, 2017
Immunotherapy with single agent nivolumab for advanced leiomyosarcoma of the uterus: Results of a phase 2 study
Eytan Ben-Ami, Constance M Barysauskas, Sarah Solomon, et al.
Page
of 118
Search research articles
Search
Showing results (901-910 of 1,171) with videos related to
Sort By:
Page
of 118
ESMO Open
|
May 13, 2025
A phase I/II study of the safety and efficacy of telaglenastat (CB-839) in combination with nivolumab in patients with metastatic melanoma, renal cell carcinoma, and non-small-cell lung cancer
M A Gouda, M H Voss, H Tawbi, et al.
NPJ Breast Cancer
|
April 26, 2025
MUC1-C dependency in drug resistant HR+/HER2- breast cancer identifies a new target for antibody-drug conjugate treatment
Ayako Nakashoji, Atrayee Bhattacharya, Hiroki Ozawa, et al.
Oncogene
|
February 22, 2007
The major lung cancer-derived mutants of ERBB2 are oncogenic and are associated with sensitivity to the irreversible EGFR/ERBB2 inhibitor HKI-272
Y Minami, T Shimamura, K Shah, et al.
JAMA Network Open
|
October 18, 2022
Diagnostic Accuracy of a Bacterial and Viral Biomarker Point-of-Care Test in the Outpatient Setting
Nathan I Shapiro, Michael R Filbin, Peter C Hou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 12, 2013
Co-clinical trials demonstrate superiority of crizotinib to chemotherapy in ALK-rearranged non-small cell lung cancer and predict strategies to overcome resistance
Zhao Chen, Esra Akbay, Oliver Mikse, et al.
Acta Physiologica (Oxford, England)
|
March 22, 2021
The Na/K-ATPase α1/Src interaction regulates metabolic reserve and Western diet intolerance
Laura C Kutz, Xiaoyu Cui, Jeffrey X Xie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 29, 2012
A phase I first-in-human trial of bardoxolone methyl in patients with advanced solid tumors and lymphomas
David S Hong, Razelle Kurzrock, Jeffrey G Supko, et al.
Journal of the American Society of Nephrology : JASN
|
April 14, 2006
Non-contrast-enhanced computerized tomography and analgesic-related kidney disease: report of the national analgesic nephropathy study
William L Henrich, Richard L Clark, Judith P Kelly, et al.
Molecular Cancer Research : MCR
|
November 29, 2022
MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast Cancer
Nami Yamashita, Yoshihiro Morimoto, Atsushi Fushimi, et al.
Cancer
|
April 26, 2017
Immunotherapy with single agent nivolumab for advanced leiomyosarcoma of the uterus: Results of a phase 2 study
Eytan Ben-Ami, Constance M Barysauskas, Sarah Solomon, et al.
Page
of 118